These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20346017)

  • 21. Neuroleptic malignant syndrome-induced massive coagulopathy treated by recombinant human soluble thrombomodulin.
    Hayashida K; Fujishima S; Nakaya N; Abe S; Shiroshita-Takeshita A; Hori S
    Am J Emerg Med; 2013 Mar; 31(3):636.e1-3. PubMed ID: 23218866
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of recombinant human soluble thrombomodulin in patients with solid carcinoma with DIC].
    Asano Y; Kashiwagi S; Shibutani M; Yamazoe S; Noda S; Sakurai K; Nagahara H; Kimura K; Kawajiri H; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohtani H; Takashima T; Yashiro M; Onoda N; Maeda K; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2503-5. PubMed ID: 25731571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors.
    Kashiwagi S; Asano Y; Takahashi K; Shibutani M; Amano R; Tomita S; Hirakawa K; Ohira M
    Anticancer Res; 2019 May; 39(5):2259-2264. PubMed ID: 31092417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient.
    Morino K; Honma Y; Kumei S; Watanabe T; Kume K; Yoshikawa I; Harada M
    Intern Med; 2018 Nov; 57(21):3079-3085. PubMed ID: 29877275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
    Kumura T; Aoyama Y; Ichihara H; Koh S; Mugitani A; Hayakawa H; Yukioka K; Kinoshita D; Nakagawa M; Yamazaki N
    Rinsho Ketsueki; 2011 Feb; 52(2):68-72. PubMed ID: 21403426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model-based analysis of covariate effects on population pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation and normal subjects.
    Tsuruta K; Yamada Y; Serada M; Tanigawara Y
    J Clin Pharmacol; 2011 Sep; 51(9):1276-85. PubMed ID: 21098690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment with recombinant thrombomodulin for B-cell lymphoma-associated hemophagocytic syndrome complicated by disseminated intravascular coagulation.
    Uni M; Yoshimi A; Maki H; Maeda D; Nakazaki K; Nakamura F; Fukayama M; Kurokawa M
    Int J Clin Exp Pathol; 2013; 6(6):1190-4. PubMed ID: 23696942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disseminated intravascular coagulation in acute monoblastic leukemia: response to heparin therapy.
    Mangal AK; Grossman L; Vickars L
    Can Med Assoc J; 1984 Mar; 130(6):731-3. PubMed ID: 6582992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment responses for disseminated intravascular coagulation in 25 children treated with recombinant thrombomodulin: a single institution experience.
    Yagasaki H; Kato M; Shimozawa K; Hirai M; Nishikawa E; Okuma H; Ishii W; Imai Y; Matsumura M; Yonezawa R; Yoshikawa K; Shichino H; Chin M; Mugishima H
    Thromb Res; 2012 Dec; 130(6):e289-93. PubMed ID: 23123162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DIC Complicating APL Successfully Treated With Recombinant Thrombomodulin Alfa.
    Saito A; Okamoto Y; Seki Y; Matsunaga M; Nakagawa S; Kodama Y; Nishikawa T; Tanabe T; Kawano Y
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):e189-90. PubMed ID: 27123666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of miliary tuberculosis complicated by disseminated intravascular coagulation and acute respiratory distress syndrome successfully treated with recombinant human soluble thrombomodulin].
    Shiraishi S; Futami S; Kurahara Y; Tsuyuguchi K; Hayashi S; Suzuki K
    Kekkaku; 2012 Dec; 87(12):771-6. PubMed ID: 23350518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies].
    Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M
    Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Case report of disseminated carcinomatosis of the bone marrow originating from gastric cancer with cancer-related disseminated intravascular coagulation successfully treated with recombinant human soluble thrombomodulin].
    Kawamoto H; Uchida Y; Ueda S; Yanagita S; Terajima H
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):363-5. PubMed ID: 25812509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of esophageal cancer with septic disseminated intravascular coagulation treated with recombinant human soluble thrombomodulin during chemoradiation therapy].
    Sasaki K; Okumura H; Uchikado Y; Minami K; Ijichi T; Owaki T; Ishigami S; Natsugoe S
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1213-5. PubMed ID: 24047782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation.
    Mimuro J; Takahashi H; Kitajima I; Tsuji H; Eguchi Y; Matsushita T; Kuroda T; Sakata Y
    Thromb Res; 2013 May; 131(5):436-43. PubMed ID: 23566534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation.
    Itoh S; Shirabe K; Kohnoe S; Sadanaga N; Kajiyama K; Yamagata M; Anai H; Harimoto N; Ikegami T; Yoshizumi T; Maehara Y
    Anticancer Res; 2016 May; 36(5):2493-6. PubMed ID: 27127163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation.
    Iba T
    Crit Care; 2015 May; 19(1):233. PubMed ID: 26002185
    [No Abstract]   [Full Text] [Related]  

  • 38. Effective control of relapsing disseminated intravascular coagulation in a patient with decompensated liver cirrhosis by recombinant soluble thrombomodulin.
    Hasebe T; Sawada K; Nakajima S; Maeda S; Abe M; Suzuki Y; Ohtake T; Hasebe C; Fujiya M; Kohgo Y
    Intern Med; 2014; 53(1):29-33. PubMed ID: 24390524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.
    Ito T; Thachil J; Asakura H; Levy JH; Iba T
    Crit Care; 2019 Aug; 23(1):280. PubMed ID: 31416465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of recombinant thrombomodulin in disseminated intravascular coagulation complicated hemophagocytic lymphohistiocytosis.
    Yamamoto M; Hori T; Hatakeyama N; Igarashi K; Inazawa N; Tsutsumi H; Suzuki N
    Indian J Pediatr; 2014 Mar; 81(3):288-91. PubMed ID: 23912823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.